BRIEF-Glycomimetics doses first patient in Phase 1 clinical trial of drug candidate GMI-1271 for multiple myeloma
September 14, 2016 at 09:24 AM EDT
* Glycomimetics Doses First Patient In Phase 1 Clinical Trial Of Drug Candidate GMI-1271 for multiple myeloma